In addition, ACKR2 expression was correlated to the expression of its counterpart ligand, i.e., CCL2, but not CCL5 and CCL8, suggesting that ACKR2 downregulation increases CCL2 in the tumor microenvironment to recruit more inflammatory cells and promote inflammation. This evidence concerns the gene CCL2 and neoplasm.